Aims to create startups originated from Japan that will develop cutting-edge medical devices to be used both in Japan and abroad through the incubation based on the needs of the medical field. Aims to promote open innovation in the medical device-related industry in Japan and contribute to the development of the medical device ecosystem in Japan.
Investment focus areas
APR 11, 2024
APR 11, 2024
RGCM I Investment Limited Partnership
Date announced
April 11, 2024
Amount investedAmount of commitment
JPY1.8 billion
Fund summary
Targets mid- to late-stage startups that are expected to IPO within the next few years, and employs a “direct secondary strategy” in which it acquires existing shareholders’ equity directly through a secondary transaction. Aims to become a platform for startups that have been forced to exit through small IPOs, etc., to raise the growth curve and create unicorns originating from Japan.
Investment focus areas
FEB 29, 2024
FEB 29, 2024
Atomico Venture VI SCSp
Date announced
February 29, 2024
Amount investedAmount of commitment
USD20 Million
Fund summary
Investments mainly in technology in Europe and has contribute to the creation of many unicorns. Aims to consider investments in Japan and contribute to the development of the startup ecosystem in Japan with the record of investing in startups in Japan and startups established by Japanese in Europe.
Investments mainly in technology in Europe and has contribute to the creation of many unicorns. Aims to consider investments in Japan and contribute to the development of the startup ecosystem in Japan with the record of investing in startups in Japan and startups established by Japanese in Europe.
Leverages its unique network and other resources to focus on pre-seed/seed stage investments. In particular, supports startups in fields where market changes are occurring due to technological innovation, or in existing industries that are using new technologies and business models, such as AI, as a competitive advantage, while also promoting the creation of new businesses.
Focuses on creating global startups in the life science field. In alliance with ARCH Venture Partners, a US firm with over 30 years of life science investment experience, leverages the US ecosystem to promote social implementation of outstanding Japanese science and technology seeds.
Collaborating with universities and research institutions, focuses on investment in deep tech, contributing to the creation of promising startups that utilize technology seeds lying dormant in academia. Setting up an investment and monitoring system for startups that solve social issues, and also engages in impact investments.
Targets mid- to late-stage startups that are expected to IPO within the next few years, and employs a “direct secondary strategy” in which it acquires existing shareholders’ equity directly through a secondary transaction. Aims to become a platform for startups that have been forced to exit through small IPOs, etc., to raise the growth curve and create unicorns originating from Japan.
Investment focus areas
AUG 4, 2023
AUG 4, 2023
Miyako Kyoto University Innovation III L.P.
Date announced
August 4, 2023
Amount investedAmount of commitment
JPY2 billion
Fund summary
Provides risk capital to deep tech startups from academia. Supporting startups from the seed/early stage, the program aims to nurture technology startups and utilize promising technologies that lie dormant in local regions.
Investment focus areas
JUL 31, 2023
JUL 31, 2023
JICVGI Opportunity Fund No.1 Investment Fund Limited Partnership
Date announced
July 31, 2023
Amount investedAmount of commitment
JPY40 billion
Fund summary
Through direct secondary investments and the provision of growth capital to listed startups, aims to be a source of support for the creation of unicorns and the sustainable and rapid growth of listed startups.
Society
Unicorn
Regional technologies
Business consolidation